PHARMAIDS PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.14 INR | +2.00% |
|
+1.34% | +13.27% |
| 04/03 | Pharmaids Pharma Completes Acquisition of Adita Bio Sys | MT |
| 02/03 | Pharmaids Pharmaceuticals Limited completed the acquisition of 99.86% stake in Adita Bio Sys Private Ltd. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 39.39M 472K | Sales 2023 | - | Capitalization | 489M 5.86M |
|---|---|---|---|---|---|
| Net income 2022 | 1M 11.99K | Net income 2023 | -75M -899K | EV / Sales 2022 | 3.17 x |
| Net cash position 2022 | 4.07M 48.86K | Net cash position 2023 | 161M 1.93M | EV / Sales 2023 | - |
| P/E ratio 2022 |
89.4
x | P/E ratio 2023 |
-3.72
x | Employees | 9 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.75% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.00% | ||
| 1 week | +1.34% | ||
| Current month | -2.70% | ||
| 1 month | -3.47% | ||
| 3 months | +4.06% | ||
| 6 months | +28.44% | ||
| Current year | +13.27% |
1 week
51.50
55.14
1 month
51.5066.10
Current year
49.6579.23
1 year
28.5079.23
3 years
10.1779.23
5 years
2.7379.23
10 years
2.0579.23
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/22/13 | |
Kaushik Kumar
CMP | Compliance Officer | - | 13/22/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 31/22/31 | |
| Director/Board Member | 50 | 27/06/27 | |
| Director/Board Member | - | 29/23/29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/24/15 | 55.14 | +2.00% | 6 153 |
| 14/24/14 | 54.06 | +2.00% | 11,558 |
| 13/24/13 | 53 | +1.40% | 13,722 |
| 10/24/10 | 52.27 | -1.99% | 3,691 |
| 09/24/09 | 53.33 | 0.00% | 5,225 |
Delayed Quote Bombay S.E., May 15, 2024 at 03:30 pm IST
More quotes
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs and intermediaries, and other. The Company operates through a single segment, Drug Formulations. Its specialty chemicals products include Retino!, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Amplimmune and other.
Sector
Pharmaceuticals
Calendar
27/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.27% | 22.83M | |
| +31.37% | 588B | |
| -2.79% | 364B | |
| +20.41% | 326B | |
| +5.49% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +11.17% | 167B | |
| +0.13% | 161B |
- Stock Market
- Equities
- PHARMAID Stock
